Evidence map›Paper›PMID 39334952›Full record

ReviewBiomolecules2024

Extracellular Matrix Components and Mechanosensing Pathways in Health and Disease.

Aikaterini Berdiaki, Monica Neagu, Petros Tzanakakis, Ioanna Spyridaki, Serge Pérez, Dragana Nikitovic

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aikaterini BerdiakiDepartment of Histology-Embryology, Medical School, University of Crete, 712 03 Heraklion, Greece.
Monica NeaguImmunology Department, "Victor Babes" National Institute of Pathology, 050096 Bucharest, Romania.ORCID 0000-0001-9339-2805
Petros TzanakakisDepartment of Histology-Embryology, Medical School, University of Crete, 712 03 Heraklion, Greece.ORCID 0000-0003-1024-0326
Ioanna SpyridakiDepartment of Histology-Embryology, Medical School, University of Crete, 712 03 Heraklion, Greece.
Serge PérezCentre de Recherche sur les Macromolécules Végétales (CERMAV), Centre National de la Recherche Scientifique (CNRS), University Grenoble Alpes, 38000 Grenoble, France.ORCID 0000-0003-3464-5352
Dragana NikitovicDepartment of Histology-Embryology, Medical School, University of Crete, 712 03 Heraklion, Greece.ORCID 0000-0003-3882-7399

Funding

Research Committee of the University of Crete 10028
6 · The paper itself

Abstract

Glycosaminoglycans (GAGs) and proteoglycans (PGs) are essential components of the extracellular matrix (ECM) with pivotal roles in cellular mechanosensing pathways. GAGs, such as heparan sulfate (HS) and chondroitin sulfate (CS), interact with various cell surface receptors, including integrins and receptor tyrosine kinases, to modulate cellular responses to mechanical stimuli. PGs, comprising a core protein with covalently attached GAG chains, serve as dynamic regulators of tissue mechanics and cell behavior, thereby playing a crucial role in maintaining tissue homeostasis. Dysregulation of GAG/PG-mediated mechanosensing pathways is implicated in numerous pathological conditions, including cancer and inflammation. Understanding the intricate mechanisms by which GAGs and PGs modulate cellular responses to mechanical forces holds promise for developing novel therapeutic strategies targeting mechanotransduction pathways in disease. This comprehensive overview underscores the importance of GAGs and PGs as key mediators of mechanosensing in maintaining tissue homeostasis and their potential as therapeutic targets for mitigating mechano-driven pathologies, focusing on cancer and inflammation.

Indexed as

Extracellular MatrixMechanotransduction, CellularAnimalsGlycosaminoglycansHumansInflammationNeoplasmsProteoglycansGlycosaminoglycansProteoglycanscancerglycosaminoglycansglypicaninflammationmechanosensingmechanotransductionproteoglycanssyndecans

Identifiers

PMID39334952
PMCPMC11430160

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.